115 related articles for article (PubMed ID: 20731719)
1. Three-step hydroxylation of vitamin D3 by a genetically engineered CYP105A1: enzymes and catalysis.
Hayashi K; Yasuda K; Sugimoto H; Ikushiro S; Kamakura M; Kittaka A; Horst RL; Chen TC; Ohta M; Shiro Y; Sakaki T
FEBS J; 2010 Oct; 277(19):3999-4009. PubMed ID: 20731719
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of a highly active vitamin D hydroxylase from Streptomyces griseolus CYP105A1.
Hayashi K; Sugimoto H; Shinkyo R; Yamada M; Ikeda S; Ikushiro S; Kamakura M; Shiro Y; Sakaki T
Biochemistry; 2008 Nov; 47(46):11964-72. PubMed ID: 18937506
[TBL] [Abstract][Full Text] [Related]
3. Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 by Streptomyces griseolus cytochrome P450SU-1.
Sawada N; Sakaki T; Yoneda S; Kusudo T; Shinkyo R; Ohta M; Inouye K
Biochem Biophys Res Commun; 2004 Jul; 320(1):156-64. PubMed ID: 15207715
[TBL] [Abstract][Full Text] [Related]
4. Sequential hydroxylation of vitamin D2 by a genetically engineered CYP105A1.
Hayashi K; Yasuda K; Yogo Y; Takita T; Yasukawa K; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Biochem Biophys Res Commun; 2016 May; 473(4):853-858. PubMed ID: 27037023
[TBL] [Abstract][Full Text] [Related]
5. Production of an active form of vitamin D
Yasuda K; Yogo Y; Sugimoto H; Mano H; Takita T; Ohta M; Kamakura M; Ikushiro S; Yasukawa K; Shiro Y; Sakaki T
Biochem Biophys Res Commun; 2017 Apr; 486(2):336-341. PubMed ID: 28302483
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of CYP105A1 (P450SU-1) in complex with 1alpha,25-dihydroxyvitamin D3.
Sugimoto H; Shinkyo R; Hayashi K; Yoneda S; Yamada M; Kamakura M; Ikushiro S; Shiro Y; Sakaki T
Biochemistry; 2008 Apr; 47(13):4017-27. PubMed ID: 18314962
[TBL] [Abstract][Full Text] [Related]
7. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
Astecker N; Bobrovnikova EA; Omdahl JL; Gennaro L; Vouros P; Schuster I; Uskokovic MR; Ishizuka S; Wang G; Reddy GS
Arch Biochem Biophys; 2004 Nov; 431(2):261-70. PubMed ID: 15488475
[TBL] [Abstract][Full Text] [Related]
8. Novel metabolism of 1 alpha,25-dihydroxyvitamin D3 with C24-C25 bond cleavage catalyzed by human CYP24A1.
Sawada N; Kusudo T; Sakaki T; Hatakeyama S; Hanada M; Abe D; Kamao M; Okano T; Ohta M; Inouye K
Biochemistry; 2004 Apr; 43(15):4530-7. PubMed ID: 15078099
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of vitamin D(3) by human CYP27A1.
Sawada N; Sakaki T; Ohta M; Inouye K
Biochem Biophys Res Commun; 2000 Jul; 273(3):977-84. PubMed ID: 10891358
[TBL] [Abstract][Full Text] [Related]
11. Kinetic studies of 25-hydroxy-19-nor-vitamin D3 and 1 alpha,25-dihydroxy-19-nor-vitamin D3 hydroxylation by CYP27B1 and CYP24A1.
Urushino N; Nakabayashi S; Arai MA; Kittaka A; Chen TC; Yamamoto K; Hayashi K; Kato S; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Drug Metab Dispos; 2007 Sep; 35(9):1482-8. PubMed ID: 17553915
[TBL] [Abstract][Full Text] [Related]
12. Biochemical Characterization of the Cytochrome P450 CYP107CB2 from Bacillus lehensis G1.
Ang SS; Salleh AB; Chor LT; Normi YM; Tejo BA; Rahman MBA; Fatima MA
Protein J; 2018 Apr; 37(2):180-193. PubMed ID: 29508210
[TBL] [Abstract][Full Text] [Related]
13. Cell specificity and properties of the C-3 epimerization of Vitamin D3 metabolites.
Kamao M; Tatematsu S; Sawada N; Sakaki T; Hatakeyama S; Kubodera N; Okano T
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):39-42. PubMed ID: 15225744
[TBL] [Abstract][Full Text] [Related]
14. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
Hughes MR; Baylink DJ; Jones PG; Haussler MR
J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
[TBL] [Abstract][Full Text] [Related]
15. Physiological significance of C-28 hydroxylation in the metabolism of 1alpha,25-dihydroxyvitamin D(2).
Rao DS; Siu-Caldera ML; Uskokovic MR; Horst RL; Reddy GS
Arch Biochem Biophys; 1999 Aug; 368(2):319-28. PubMed ID: 10441383
[TBL] [Abstract][Full Text] [Related]
16. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cytochrome P450 CYP109E1 from Bacillus megaterium as a novel vitamin D
Abdulmughni A; Jóźwik IK; Putkaradze N; Brill E; Zapp J; Thunnissen AW; Hannemann F; Bernhardt R
J Biotechnol; 2017 Feb; 243():38-47. PubMed ID: 28043840
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the stability of CYP105A1 and its variants engineered for production of active forms of vitamin D.
Takita T; Sakuma H; Ohashi R; Nilouyal S; Nemoto S; Wada M; Yogo Y; Yasuda K; Ikushiro S; Sakaki T; Yasukawa K
Biosci Biotechnol Biochem; 2022 Mar; 86(4):444-454. PubMed ID: 35134837
[TBL] [Abstract][Full Text] [Related]
19. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
20. Isolation and properties of the CYP2D25 promoter: transcriptional regulation by vitamin D3 metabolites.
Ellfolk M; Norlin M; Wikvall K
Biochem Biophys Res Commun; 2006 Jun; 345(2):568-72. PubMed ID: 16690021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
